We are delighted to introduce you to our new RSC Pharmaceutics Advisory Board member, Dr Defang Ouyang.
Dr Defang Ouyang is an Associate Professor at the University of Macau. Since 2011, he has pioneered the integration of artificial intelligence, big data and multi-scale modelling techniques in the field of drug delivery.
“The Royal Society of Chemistry (RSC) is among the oldest scientific and research organizations. With a keen interest in computational pharmaceutics, I am both honoured and thrilled to be a member of RSC Pharmaceutics.” – Dr Defang Ouyang.
Read some of Dr Ouyang’s research:
AI-directed formulation strategy design initiates rational drug development
Nannan Wang, Jie Dong, Defang Ouyang
J. Control. Release, 2025, 378, 619-636
Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery
Wei Wang, Kepan Chen, Ting Jiang, Yiyang Wu, Zheng Wu, Hang Ying, Hang Yu, Jing Lu, Jinzhong Lin, Defang Ouyang
Nat. Commun., 2024, 15, 10804
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Submit to RSC Pharmaceutics today!
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.